D-1263-2014 Class I Terminated
FDA drug recall D-1263-2014 was initiated by Medisca Inc. on Oct 21, 2013 and is designated Class I. Reason for recall: Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label. The recall status is terminated (terminated Nov 16, 2016). Affected quantity: 296 units.
Recall details
- Product Type
- Drugs
- Report Date
- May 7, 2014
- Initiation Date
- Oct 21, 2013
- Termination Date
- Nov 16, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 296 units
Product description
Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compounding, manufacturing, processing or repacking only in accordance with FDA regulations and applicable law. Potency 5489.6IU/mg. Packed by Medisca, Inc. Irving, TX, 75063, USA NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6. Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16, CAS 9002-61-3; and 101799/A, Exp: 05/16, CAS: 9002-61-3
Reason for recall
Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.
Distribution pattern
Nationwide
Code information
Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16, CAS 9002-61-3; and 101799/A, Exp: 05/16, CAS: 9002-61-3. NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1263-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026